At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Device: Trial nasal mask (F&P)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Evaluation of a New Nasal Mask for the Treatment of Obstructive Sleep Apnea
In Brief
A clinical study evaluating Device: Trial nasal mask (F&P) for Obstructive Sleep Apnea. Completed, enrolled 45 participants across 1 site.
Detailed Summary
This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartAug 2019
Primary CompletionApr 2020
Study CompletionAug 2020
TodayJul 2026
First PostedJul 9, 2019
Enrollment StartAug 5, 2019
Primary CompletionApr 30, 2020
Study CompletionAug 30, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.0 years ago
Interventions
Device: Trial nasal mask (F&P)device
This trial nasal mask will serve as the participant's primary PAP/BPAP therapy mask for the duration of the trial period (from Visit 2 to Visit 3). For participants taking part in the study extension, they will be using the trial nasal mask as their primary PAP/BPAP therapy mask for 6 months after Visit 3.